Cholesterol Sulfotransferase SULT2B1b Modulates Sensitivity to Death Receptor Ligand TNFα in Castration-Resistant...

Area of Science:

• Molecular Biology
• Cancer Research
• Cellular Signaling

Background:

• Cholesterol sulfotransferase SULT2B1b influences androgen receptor activity and cell growth.
• The precise mechanisms of SULT2B1b's role in prostate cancer remain unclear.
• The specific advantages conferred by SULT2B1b expression in prostate cancer are not well understood.

Purpose of the Study:

• To elucidate the mechanism by which SULT2B1b affects prostate cancer cells.
• To investigate the role of SULT2B1b in TNF-mediated signaling and apoptosis.
• To determine the clinical relevance of SULT2B1b expression in human prostate cancer.

Main Methods:

• Single-cell mRNA sequencing to compare SULT2B1b knockdown (KD) versus control KD LNCaP cells.
• Analysis of differentially expressed genes and canonical pathways, including death receptor signaling.
• Examination of TNFα expression, NF-κB activation, and TNF-mediated apoptosis.
• Investigation of SULT2B1b overexpression effects and correlation with human prostate cancer patient datasets.

Main Results:

• Over 2,000 differentially expressed genes and altered pathways were identified upon SULT2B1b KD.
• SULT2B1b KD increased TNFα expression and activated NF-κB in a TNF-dependent manner.
• SULT2B1b KD significantly enhanced TNF-mediated apoptosis in both sensitive and resistant prostate cancer cells.
• SULT2B1b overexpression decreased sensitivity to TNF-induced cell death.
• Human prostate cancer data showed an inverse correlation between SULT2B1b expression and TNF-related genes (TNF, CD40LG, FADD, NFKB1).

Conclusions:

• SULT2B1b expression in prostate cancer cells confers resistance to TNF-mediated apoptosis.
• SULT2B1b may provide a growth advantage to prostate cancer cells.
• Targeting SULT2B1b could enhance therapeutic efficacy of TNF treatment in advanced prostate cancer.